Trial · NCT01893151
Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI
NCT01893151, Phase 4, Unknown, Jiangsu Simcere Pharmaceutical Co., Ltd.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI. Trials, record NCT01893151. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01893151
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI
- NCT number
- NCT01893151
- Status
- Unknown
- Phases
- Phase 4
- Enrollment
- 200 participants, estimated
- Lead sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Conditions
- Rheumatoid Arthritis
- Interventions
- Iguratimod, Iguratimod placebo
- First posted
- 2013-07-08
- Last updated
- 2014-10-23
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline in RA magnetic resonance imaging scoring system (RAMRIS) | week 52 | |
| Primary | Change from baseline in modified Total Sharp Score (mTSS) | week 52 | |
| Primary | Percentage of patients with ACR 20 response | week 52 | |
| Primary | Change in Disease Activity as measured by the DAS28 | week 52 | |
| Secondary | Change from baseline in RAMRIS | week 24 | |
| Secondary | Change from baseline in mTSS | week 24 | |
| Secondary | Percentage of patients with ACR 20 response | week 10, week 24, week 40 | |
| Secondary | Change from baseline in Disease Activity Score 28 (DAS28) | : week 10, week 24, week 40 | |
| Secondary | Percentage of patients with ACR 50 response | week 10, week 24, week 40, week 52 | |
| Secondary | Percentage of patients with ACR 70 response | week 10, week 24, week 40, week 52 |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01893151
GET https://conductscience.org/api/trials/v1/NCT01893151/registered